All five model answers are ready. Here is a quick guide to what each answer covers:
Quick Reference Summary:
Q6 - STD Kits: Covers the rationale for syndromic management, all 5 NACO kit compositions (urethral discharge, vaginal discharge, genital ulcer, inguinal bubo, PID), partner treatment packs, and limitations.
Q7 - Histoid & Lucio Leprosy: Histoid leprosy (Wade, 1963) - spindle-cell granuloma, high BI, dermatofibroma-like nodules on normal-looking skin. Lucio leprosy - M. lepromatosis, diffuse non-nodular "lepra bonita," Lucio phenomenon (ascending purpura/ulceration), endothelial pathogenesis, poorly responsive to steroids/thalidomide.
Q8 - Rehabilitation in Leprosy & Atypical PB Leprosy: Four levels of rehab (medical/DPMR, surgical/RCS, socioeconomic, CBR); WHO disability grading; NLEP specifics (83 RCS centers, MCR footwear, ulcer kits, ASHA). Atypical PB leprosy includes pure neuritic, single lesion, reactional presentation, and mimickers.
Q9 - Prenatal Syphilis & Ulcerative STD-HIV Coinfection: Full Hutchinson's triad, early vs late congenital syphilis, snuffles, periostitis, penicillin dosing in neonates; plus the bidirectional HSV-2/syphilis/chancroid HIV amplification mechanism with risk quantification.
Q10 - STD Investigations & Gonorrhoea Complications: Complete lab panel by pathogen (NAAT, dark-field, Thayer-Martin culture, VDRL/TPHA, PCR). Gonorrhoea complications from Bartholinitis and PID (with Fitz-Hugh-Curtis) to DGI arthritis-dermatitis syndrome, ophthalmia neonatorum, endocarditis/meningitis, plus current ceftriaxone-based treatment.